3-114315251-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001348800.3(ZBTB20):​c.*23754G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.904 in 152,210 control chromosomes in the GnomAD database, including 62,719 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.90 ( 62715 hom., cov: 31)
Exomes 𝑓: 0.80 ( 4 hom. )

Consequence

ZBTB20
NM_001348800.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.42

Publications

2 publications found
Variant links:
Genes affected
ZBTB20 (HGNC:13503): (zinc finger and BTB domain containing 20) This gene, which was initially designated as dendritic cell-derived BTB/POZ zinc finger (DPZF), belongs to a family of transcription factors with an N-terminal BTB/POZ domain and a C-terminal DNA-bindng zinc finger domain. The BTB/POZ domain is a hydrophobic region of approximately 120 aa which mediates association with other BTB/POZ domain-containing proteins. This gene acts as a transcriptional repressor and plays a role in many processes including neurogenesis, glucose homeostasis, and postnatal growth. Mutations in this gene have been associated with Primrose syndrome as well as the 3q13.31 microdeletion syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
ZBTB20 Gene-Disease associations (from GenCC):
  • Primrose syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Genomics England PanelApp, Ambry Genetics
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.971 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001348800.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
NM_001348800.3
MANE Select
c.*23754G>A
3_prime_UTR
Exon 12 of 12NP_001335729.1Q9HC78-1
ZBTB20
NM_001164342.2
c.*23754G>A
3_prime_UTR
Exon 5 of 5NP_001157814.1Q9HC78-1
ZBTB20
NM_001348803.3
c.*23754G>A
3_prime_UTR
Exon 14 of 14NP_001335732.1Q9HC78-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
ENST00000675478.1
MANE Select
c.*23754G>A
3_prime_UTR
Exon 12 of 12ENSP00000501561.1Q9HC78-1
ZBTB20
ENST00000357258.8
TSL:1
c.*23754G>A
3_prime_UTR
Exon 10 of 10ENSP00000349803.3Q9HC78-2
ENSG00000259976
ENST00000570269.2
TSL:6
n.14464G>A
non_coding_transcript_exon
Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.905
AC:
137586
AN:
152082
Hom.:
62691
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.782
Gnomad AMI
AF:
0.944
Gnomad AMR
AF:
0.951
Gnomad ASJ
AF:
0.952
Gnomad EAS
AF:
0.993
Gnomad SAS
AF:
0.929
Gnomad FIN
AF:
0.986
Gnomad MID
AF:
0.953
Gnomad NFE
AF:
0.944
Gnomad OTH
AF:
0.918
GnomAD4 exome
AF:
0.800
AC:
8
AN:
10
Hom.:
4
Cov.:
0
AF XY:
1.00
AC XY:
4
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.800
AC:
8
AN:
10
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.904
AC:
137659
AN:
152200
Hom.:
62715
Cov.:
31
AF XY:
0.908
AC XY:
67599
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.782
AC:
32428
AN:
41476
American (AMR)
AF:
0.951
AC:
14561
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.952
AC:
3304
AN:
3472
East Asian (EAS)
AF:
0.993
AC:
5136
AN:
5170
South Asian (SAS)
AF:
0.928
AC:
4477
AN:
4822
European-Finnish (FIN)
AF:
0.986
AC:
10460
AN:
10612
Middle Eastern (MID)
AF:
0.946
AC:
278
AN:
294
European-Non Finnish (NFE)
AF:
0.944
AC:
64214
AN:
68024
Other (OTH)
AF:
0.918
AC:
1940
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
633
1266
1899
2532
3165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.933
Hom.:
111806
Bravo
AF:
0.896
Asia WGS
AF:
0.933
AC:
3243
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.45
DANN
Benign
0.82
PhyloP100
-1.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4682534; hg19: chr3-114034098; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.